Evaluating the potential of Vitamin D and curcumin to alleviate inflammation and mitigate the progression of osteoarthritis through their effects on human chondrocytes: A proof-of-concept investigation
PLOS ONE · 29.12.2023 · 18 (12) · e0290739
DOI: 10.1371/journal.pone.0290739 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 29.12.2023. Verfasst von Rajashree Patnaik und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine and Health Sciences, Mohammed Bin Rashid University of Medicine, and Health Sciences (MBRU), Dubai, United Arab Emirates. Hauptthemen laut MEDLINE: Curcumin, Osteoarthritis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Osteoarthritis (OA) is a chronic degenerative joint disorder primarily affecting the elderly, characterized by a prominent inflammatory component. The long-term side effects associated with current therapeutic approaches necessitate the development of safer and more efficacious alternatives. Nutraceuticals, such as Vitamin D and curcumin, present promising therapeutic potentials due to their safety, efficacy, and cost-effectiveness. In this study, we utilized a proinflammatory human chondrocyte model of OA to assess the anti-inflammatory properties of Vitamin D and curcumin, with a particular focus on the Protease-Activated Receptor-2 (PAR-2) mediated inflammatory pathway. Employing a robust siRNA approach, we effectively modulated the expression of PAR-2 to understand its role in the inflammatory process. Our results reveal that both Vitamin D and curcumin attenuate the expression of PAR-2, leading to a reduction in the downstream proinflammatory cytokines, such as Tumor Necrosis Factor-alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 8 (IL-8), implicated in the OA pathogenesis. Concurrently, these compounds suppressed the expression of Receptor Activator of Nuclear Factor kappa-Β Ligand (RANKL) and its receptor RANK, which are associated with PAR-2 mediated TNF-α stimulation. Additionally, Vitamin D and curcumin downregulated the expression of Interferon gamma (IFN-γ), known to elevate RANKL levels, underscoring their potential therapeutic implications in OA. This study, for the first time, provides evidence of the mitigating effect of Vitamin D and curcumin on PAR-2 mediated inflammation, employing an siRNA approach in OA. Thus, our findings pave the way for future research and the development of novel, safer, and more effective therapeutic strategies for managing OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Medicine and Health Sciences, Mohammed Bin Rashid University of Medicine, and Health Sciences (MBRU), Dubai, United Arab Emirates.
- Department of Health Promotion, Mother and Child Care, Internal Medicine, and Medical Specialties (Promise), University of Palermo, Palermo, Italy.
- Centre for Medical Education, University of Dundee, Dundee, United Kingdom.
ORCID-Profile: Yajnavalka Banerjee
Zitieren
APA
Patnaik, R., Riaz, S., Sivani, B. M., Faisal, S., Naidoo, N., Rizzo, M., & Banerjee, Y. (2023). Evaluating the potential of Vitamin D and curcumin to alleviate inflammation and mitigate the progression of osteoarthritis through their effects on human chondrocytes: A proof-of-concept investigation. PLOS ONE, 18(12), e0290739. https://doi.org/10.1371/journal.pone.0290739
Vancouver
Patnaik R, Riaz S, Sivani BM, Faisal S, Naidoo N, Rizzo M, et al. Evaluating the potential of Vitamin D and curcumin to alleviate inflammation and mitigate the progression of osteoarthritis through their effects on human chondrocytes: A proof-of-concept investigation. PLOS ONE. 2023;18(12):e0290739. doi:10.1371/journal.pone.0290739
BibTeX
@article{Patnaik2023,
author = {Patnaik, Rajashree and Riaz, Sumbal and Sivani, Bala Mohan and Faisal, Shemima and Naidoo, Nerissa and Rizzo, Manfredi and Banerjee, Yajnavalka},
title = {Evaluating the potential of Vitamin D and curcumin to alleviate inflammation and mitigate the progression of osteoarthritis through their effects on human chondrocytes: A proof-of-concept investigation},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {12},
pages = {e0290739},
doi = {10.1371/journal.pone.0290739}
}
EUVIMED